Highlights

MediaPharma S.r.l.
A Company focused on the discovery and development of innovative drugs for the treatment of cancer and other diseases with unmet medical need.

Human CD3 x TN, bispecific antibody

BACKGROUND
The double specificity of the reagent overcomes the limitation of single antibodies which do not activate T lymphocytes which lack Fc receptors and bind the target antigen with both Fab regions. The bispecific antibody possesses high cytotoxic potential even for cell and stromal targets expressed at low levels.

PRODUCT
Each vial contains the indicated amount of IgG (HPLC, Prot. A) in 0,1% gelatine and 0,05% NaN3.

SPECIFICITY
Double specificity for CD3 expressed on cytotoxic T lymphocytes and Tenascin C stably expressed in the stroma of several malignancies.

STORAGE
Store frozen, avoid repeated freeze-thawing. Stable for 2 yrs.

SHIPPING CONDITIONS
Room temperature.

RESEARCH USE
This antibody is for laboratory research use only, not for human or in-vivo use.

APPLICATIONS

See enlisted references.

REFERENCES
1. Int J Cancer (1991) 47: 811.
2. Int J Cancer (1995) 61: 509.

Sku
MP-AA-23
Description
CLONE CD3 X TN
Product Options
#OptionPriceDownload
1HPLC, Prot. A - 50 µg€300,00MP-AA-23
Order CLONE CD3 X TN HPLC, Prot. A - 50 µg @ €300,00

Company

R&D

Careers

Business